Drug screen in patient cells suggests quinacrine to be repositioned for treatment of acute myeloid leukemia

Por Eriksson, A, Österroos, A, Hassan, S, Gullbo, J, Rickardson, L, Jarvius, M, Nygren, P, Fryknäs, M, Höglund, M, Larsson, R
Publicado no Blood Cancer J (2015)

Identification of molecular mechanisms for cellular drug resistance by combining drug activity and gene expression profiles

Por Rickardson, L, Fryknäs, M, Dhar, S, Lövborg, H, Gullbo, J, Rydåker, M, Nygren, P, Gustafsson, M G, Larsson, R, Isaksson, A
Publicado em 2005

Hsp90 is expressed and represents a therapeutic target in human oesophageal cancer using the inhibitor 17-allylamino-17-demethoxygeldanamycin

Por Wu, X, Wanders, A, Wardega, P, Tinge, B, Gedda, L, Bergstrom, S, Sooman, L, Gullbo, J, Bergqvist, M, Hesselius, P, Lennartsson, J, Ekman, S
Publicado em 2009

APR-246 overcomes resistance to cisplatin and doxorubicin in ovarian cancer cells

Por Mohell, N, Alfredsson, J, Fransson, Å, Uustalu, M, Byström, S, Gullbo, J, Hallberg, A, Bykov, V J N, Björklund, U, Wiman, K G
Publicado no Cell Death Dis (2015)